TOPEKA— The number of confirmed coronavirus cases in Kansas increased by 269 to a total of 315,769, the state health department reported Friday afternoon.&nbsp;

The state reported 3 new COVID-19 deaths for a total of 5106.

<a href="https://www.kansasvaccine.gov/158/Data">Click here for Data</a> about the COVID-19 vaccine.

<a href="https://www.coronavirus.kdheks.gov/160/COVID-19-in-Kansas">Click here&nbsp;</a>for additional virus numbers from the KDHE.

TOPEKA— The number of confirmed coronavirus cases in Kansas increased by 269 to a total of 315,769, the state health department reported Friday afternoon.&nbsp;The state reported 3 new COVID-19 deaths for a total of 5106.<a href="https://www.kansasvaccine.gov/158/Data">Click here for Data</a> about the COVID-19 vaccine.<a href="https://www.coronavirus.kdheks.gov/160/COVID-19-in-Kansas">Click here&nbsp;</a>for additional virus numbers from the KDHE.<figure>
 <img src="https://media.eaglewebservices.com/public/2021/6/1623431244684.png" alt="Friday June 11, 2021 KDHE image" />
 <figcaption>Friday June 11, 2021 KDHE image</figcaption>
 </figure>

KDHE: Latest coronavirus numbers in Kansas

WASHINGTON — U.S. health officials are investigating what appear to be higher than expected reports of heart inflammation in male teens and young adults after they get a second dose of the Pfizer and Moderna vaccines.

It’s not clear if the heart inflammation is caused by the shots and the reports still are rare, according to the Centers for Disease Control and Prevention. It urges everyone 12 and older to get vaccinated.

As of May 31, the agency had 275 preliminary reports of such inflammation in 16- to 24-year-olds, CDC’s Dr. Tom Shimabukuro told a government vaccine meeting on Thursday. That’s out of more than 12 million second-dose injections of the vaccines.

The cases seem to occur more often in men and in younger people, and most already have fully recovered, he said.

This kind of heart inflammation can be caused by a variety of infections, including a bout of COVID-19, as well as certain medications — and there have been rare reports following other types of vaccinations.

The CDC’s vaccine advisory committee will meet on June 18 to further evaluate the possible risk.

WASHINGTON — U.S. health officials are investigating what appear to be higher than expected reports of heart inflammation in male teens and young adults after they get a second dose of the Pfizer and Moderna vaccines.It’s not clear if the heart inflammation is caused by the shots and the reports still are rare, according to the Centers for Disease Control and Prevention. It urges everyone 12 and older to get vaccinated.As of May 31, the agency had 275 preliminary reports of such inflammation in 16- to 24-year-olds, CDC’s Dr. Tom Shimabukuro told a government vaccine meeting on Thursday. That’s out of more than 12 million second-dose injections of the vaccines.The cases seem to occur more often in men and in younger people, and most already have fully recovered, he said.This kind of heart inflammation can be caused by a variety of infections, including a bout of COVID-19, as well as certain medications — and there have been rare reports following other types of vaccinations.The CDC’s vaccine advisory committee will meet on June 18 to further evaluate the possible risk.

CDC looking into reports of heart inflammation from vaccine

TOPEKA— The number of confirmed coronavirus cases in Kansas increased by 401 to a total of 315,500, the state health department reported Wednesday afternoon.&nbsp;

The state reported 16 new COVID-19 deaths for a total of 5103.

TOPEKA— The number of confirmed coronavirus cases in Kansas increased by 401 to a total of 315,500, the state health department reported Wednesday afternoon.&nbsp;The state reported 16 new COVID-19 deaths for a total of 5103.<a href="https://www.kansasvaccine.gov/158/Data">Click here for Data</a> about the COVID-19 vaccine.<a href="https://www.coronavirus.kdheks.gov/160/COVID-19-in-Kansas">Click here&nbsp;</a>for additional virus numbers from the KDHE.<figure>
 <img src="https://media.eaglewebservices.com/public/2021/6/1623258207751.png" alt="" />
 <figcaption></figcaption>
 </figure>

The head of the Centers for Disease Control and Prevention on Sunday defended the decision to ease mask-wearing guidance for fully vaccinated people, stressing that increasing political pressure had nothing to do with the abrupt shift in guidelines.

“I’m delivering the science as the science is delivered to the medical journals. And it evolved," CDC Director Rochelle Walensky said on FOX News Sunday. “I deliver it as soon as I can when we have that information available.”

Under the new guidelines released last week, fully vaccinated people — those who are two weeks past their final dose of a COVID-19 vaccine — can quit wearing masks outdoors in crowds and in most indoor settings and give up social distancing.

However, partially vaccinated or unvaccinated people should continue wearing masks, the agency said. The guidance also still calls for masks in crowded indoor settings including buses, airplanes, hospitals, prisons and homeless shelters.

The sudden change sparked praise from those eager to return to pre-pandemic life, particularly those who see the new guidelines as a way to reopen workplaces, schools and other venues that went dark during the pandemic.

Yet concerns have been raised from those who say there's no easy way for businesses and others to determine who is fully vaccinated and who is not. Instead, many will have to rely on an honor system as many states and communities have already been lifting mask mandates amid improving virus numbers and as more Americans have been shedding face coverings after getting shots.

“I would imagine within a period of just a couple of weeks, you’re going to start to see significant clarification of some of the actually understandable and reasonable questions that people are asking,” Dr. Anthony Fauci, the face of the U.S. government’s pandemic response, said on Face the Nation.

The timing of the change has also faced questions. Just days earlier, Walensky had defended the agency's strict mask guidance in front of a Senate committee where some Republicans on the panel described the CDC's guidance as “unworkable.”

When pressed about the quick turnaround on the agency's stance on mask wearing, Walensky said the agency was not giving in to pressure but instead needed time to review evolving science.

“I can tell you it certainly would have been easier if the science had evolved a week earlier and I didn’t have to go to Congress making those statements. But I’m delivering the science as the science is delivered to the medical journals,” she said.

To date more than 156 million Americans, or more than 47% of the population, have received at least one dose of COVID-19 vaccine, and more than 121 million are fully vaccinated.

Walensky cautioned that even with the new guidelines, it was still too early to “declare victory,” but added that she was “cautiously optimistic" about the pandemic.

“We have to remain humble. We’ve had way too many curveballs in this pandemic come to us. But I am really cautiously optimistic that we are in a good place right now, that cases continue to come down,” she said.

But, she added, even though the guidance has changed, “there’s no need for everybody to start ripping off their masks."

“There is no mandate to take it off. What we’re saying is, now this is safe," she said. “Work at your own speed, work with your own family and your own businesses to remove them when necessary."

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/5/1621194714478.png" alt="Walensky during a White House briefing last week said, "We have all longed for this moment - when we can get back to some sense of normalcy – and that moment has come for those who are fully vaccinated!"&nbsp; Photo courtesy White House" />
 <figcaption>Walensky during a White House briefing last week said, "We have all longed for this moment - when we can get back to some sense of normalcy – and that moment has come for those who are fully vaccinated!"&nbsp; Photo courtesy White House</figcaption>
 </figure>By KIMBERLEE KRUESI, Associated PressThe head of the Centers for Disease Control and Prevention on Sunday defended the decision to ease mask-wearing guidance for fully vaccinated people, stressing that increasing political pressure had nothing to do with the abrupt shift in guidelines.“I’m delivering the science as the science is delivered to the medical journals. And it evolved," CDC Director Rochelle Walensky said on FOX News Sunday. “I deliver it as soon as I can when we have that information available.”Under the new guidelines released last week, fully vaccinated people — those who are two weeks past their final dose of a COVID-19 vaccine — can quit wearing masks outdoors in crowds and in most indoor settings and give up social distancing.However, partially vaccinated or unvaccinated people should continue wearing masks, the agency said. The guidance also still calls for masks in crowded indoor settings including buses, airplanes, hospitals, prisons and homeless shelters.The sudden change sparked praise from those eager to return to pre-pandemic life, particularly those who see the new guidelines as a way to reopen workplaces, schools and other venues that went dark during the pandemic.Yet concerns have been raised from those who say there's no easy way for businesses and others to determine who is fully vaccinated and who is not. Instead, many will have to rely on an honor system as many states and communities have already been lifting mask mandates amid improving virus numbers and as more Americans have been shedding face coverings after getting shots.“I would imagine within a period of just a couple of weeks, you’re going to start to see significant clarification of some of the actually understandable and reasonable questions that people are asking,” Dr. Anthony Fauci, the face of the U.S. government’s pandemic response, said on Face the Nation.The timing of the change has also faced questions. Just days earlier, Walensky had defended the agency's strict mask guidance in front of a Senate committee where some Republicans on the panel described the CDC's guidance as “unworkable.”When pressed about the quick turnaround on the agency's stance on mask wearing, Walensky said the agency was not giving in to pressure but instead needed time to review evolving science.“I can tell you it certainly would have been easier if the science had evolved a week earlier and I didn’t have to go to Congress making those statements. But I’m delivering the science as the science is delivered to the medical journals,” she said.To date more than 156 million Americans, or more than 47% of the population, have received at least one dose of COVID-19 vaccine, and more than 121 million are fully vaccinated.Walensky cautioned that even with the new guidelines, it was still too early to “declare victory,” but added that she was “cautiously optimistic" about the pandemic.“We have to remain humble. We’ve had way too many curveballs in this pandemic come to us. But I am really cautiously optimistic that we are in a good place right now, that cases continue to come down,” she said.But, she added, even though the guidance has changed, “there’s no need for everybody to start ripping off their masks."“There is no mandate to take it off. What we’re saying is, now this is safe," she said. “Work at your own speed, work with your own family and your own businesses to remove them when necessary."

CDC director defends decision to ditch masks

WASHINGTON (AP) - U.S. health advisers endorsed use of Pfizer’s COVID-19 vaccine in kids as young as 12 on Wednesday, just as expected new guidelines say it’s OK for people of any age to get the shot at the same time as other needed vaccinations.

The sprint to vaccinate millions of middle and high school students has already started in parts of the country, as a long line of kids rolled up their sleeves in suburban Atlanta for a first dose Wednesday. But much of the nation was awaiting recommendations by the Centers for Disease Control and Prevention that Pfizer’s vaccine, already used for months in those 16 and older, was a good choice for 12- to 15-year-olds, too. The CDC was expected to accept its advisers’ recommendation.

“It just felt like a flu shot, honestly,” said Meredith Rogers, a 14-year-old middle school student from Decatur, Georgia, after getting her vaccination.

Michelle Rogers, Meredith’s mother, said she hoped the youth vaccinations would help bring some normalcy back.

“A little apprehensive, but you know what? This is a step towards getting life back to normal so, we’re all in,” Michelle Rogers said with a slight fist pump.

Earlier in the week, the Food and Drug Administration authorized emergency use of the two-shot vaccine made by Pfizer and its German partner, BioNTech. A study of more than 2,000 12- to 15-year-olds found the same dose adults use is safe and strongly protective in the kids, too.

Among the outstanding questions: Is it OK to get vaccinated against COVID-19 at the same doctor’s visit as people receive some routine vaccinations? That’s an urgent back-to-school concern especially for the 12- to 15-year-olds, who have missed out on regularly scheduled vaccines during the pandemic — but also an issue for adults, too.

The CDC until now has recommended not getting other vaccinations within two weeks of a COVID-19 shot, mostly as a precaution so that safety monitors could spot if any unexpected side effects crop up. But the CDC said Wednesday it is changing that advice because the COVID-19 vaccines have proved so safe — and that health workers can decide to give another needed vaccine at the same time.

The American Academy of Pediatrics on Wednesday also endorsed the Pfizer vaccine for the 12-and-up crowd — and agreed that it’s fine to give more than one vaccine at the same time, especially for kids who are behind on their regular vaccinations.

In the Pfizer study, there were no cases of COVID-19 among volunteers given the two-shot vaccination compared with 16 in the group given dummy shots. Kids also developed higher levels of virus-fighting antibodies than vaccinated adults. Side effects are the same as adults experience, mostly sore arms and flu-like fever, chills or aches that signal the immune system is revving up.

Vaccinating Americans of all ages will be critical to getting back to normal, and there’s plenty of supply for the nation’s nearly 17 million 12- to 15-year-olds.

In addition to the mass vaccination sites and health department rollouts that were key for adults, many states will be offering kids more familiar options -- shipping doses to pediatricians and even to schools.

Pfizer is not the only company seeking to lower the age limit for its vaccine. Moderna recently said preliminary results from its study in 12- to 17-year-olds show strong protection and no serious side effects, data the FDA will need to scrutinize.

As for even younger children, both companies have begun tests in youngsters ages 6 months to 11 years. Those studies explore if different doses are needed at the youngest ages, and FDA plans to hold a public meeting next month to debate exactly what evidence is needed.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/12/1608677701818.png" alt="A worker at Truman Medical Center in Kansas City prepares doses of Pfizer-BioNTech's vaccine against the virus that causes COVID-19 photo courtesyTruman Medical Center" />
 <figcaption>A worker at Truman Medical Center in Kansas City prepares doses of Pfizer-BioNTech's vaccine against the virus that causes COVID-19 photo courtesyTruman Medical Center</figcaption>
 </figure>WASHINGTON (AP) - U.S. health advisers endorsed use of Pfizer’s COVID-19 vaccine in kids as young as 12 on Wednesday, just as expected new guidelines say it’s OK for people of any age to get the shot at the same time as other needed vaccinations.The sprint to vaccinate millions of middle and high school students has already started in parts of the country, as a long line of kids rolled up their sleeves in suburban Atlanta for a first dose Wednesday. But much of the nation was awaiting recommendations by the Centers for Disease Control and Prevention that Pfizer’s vaccine, already used for months in those 16 and older, was a good choice for 12- to 15-year-olds, too. The CDC was expected to accept its advisers’ recommendation.“It just felt like a flu shot, honestly,” said Meredith Rogers, a 14-year-old middle school student from Decatur, Georgia, after getting her vaccination.Michelle Rogers, Meredith’s mother, said she hoped the youth vaccinations would help bring some normalcy back.“A little apprehensive, but you know what? This is a step towards getting life back to normal so, we’re all in,” Michelle Rogers said with a slight fist pump.Earlier in the week, the Food and Drug Administration authorized emergency use of the two-shot vaccine made by Pfizer and its German partner, BioNTech. A study of more than 2,000 12- to 15-year-olds found the same dose adults use is safe and strongly protective in the kids, too.Among the outstanding questions: Is it OK to get vaccinated against COVID-19 at the same doctor’s visit as people receive some routine vaccinations? That’s an urgent back-to-school concern especially for the 12- to 15-year-olds, who have missed out on regularly scheduled vaccines during the pandemic — but also an issue for adults, too.The CDC until now has recommended not getting other vaccinations within two weeks of a COVID-19 shot, mostly as a precaution so that safety monitors could spot if any unexpected side effects crop up. But the CDC said Wednesday it is changing that advice because the COVID-19 vaccines have proved so safe — and that health workers can decide to give another needed vaccine at the same time.The American Academy of Pediatrics on Wednesday also endorsed the Pfizer vaccine for the 12-and-up crowd — and agreed that it’s fine to give more than one vaccine at the same time, especially for kids who are behind on their regular vaccinations.In the Pfizer study, there were no cases of COVID-19 among volunteers given the two-shot vaccination compared with 16 in the group given dummy shots. Kids also developed higher levels of virus-fighting antibodies than vaccinated adults. Side effects are the same as adults experience, mostly sore arms and flu-like fever, chills or aches that signal the immune system is revving up.Vaccinating Americans of all ages will be critical to getting back to normal, and there’s plenty of supply for the nation’s nearly 17 million 12- to 15-year-olds.In addition to the mass vaccination sites and health department rollouts that were key for adults, many states will be offering kids more familiar options -- shipping doses to pediatricians and even to schools.Pfizer is not the only company seeking to lower the age limit for its vaccine. Moderna recently said preliminary results from its study in 12- to 17-year-olds show strong protection and no serious side effects, data the FDA will need to scrutinize.As for even younger children, both companies have begun tests in youngsters ages 6 months to 11 years. Those studies explore if different doses are needed at the youngest ages, and FDA plans to hold a public meeting next month to debate exactly what evidence is needed.

US advisers endorse Pfizer COVID shot for kids 12 and up


HUTCHINSON,
Kan. — 
Karen Hammersmith with the Reno County Health Department says she has spoken to the local doctors that work with kids and parents who are considering vaccinating their 12-15 year olds with the Pfizer vaccine once it is cleared later this week should talk to their doctor.

"They definitely want anybody that wants the vaccine to get the vaccine especially if you have some high-risk factors," Hammersmith said. "You can also get it if you don't have high-risk factors, because the vaccine is improved. We know that what it prevents is serious complications, which we have seen in that younger generation. We just haven't seen as much of that."

It is the intent of the Health Department to get in some Pfizer vaccine, in light of the new developments.

"We plan to order the vaccine for next week," Hammersmith said. "Once a week, we put in an order to KDHE and then they get that from the federal government as to how much vaccine is available. We are going to order some Pfizer. It's got a little bit of an issue with the shelf life."

The U.S. Food and Drug Administration in late February approved storage and transportation of the Pfizer vaccine at standard freezer temperatures for up to two weeks instead of ultra-cold conditions. Before that, it had required ultra-cold storage.

Young adults are also encouraged to get their shots.

"We still want to push that vaccine out to those specifically in the 20 to 49-year-old group, too, that we have a lot less people vaccinated," Hammersmith said. "You can come as a family. We can get the parents, we can get the kids 12 and up all vaccinated at the same time."

Until the county's shipment can get in, you can look at vaccinefinder.org to see who currently has the Pfizer shot.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1606243325401.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>
By
NICK GOSNELL
Hutch
Post
HUTCHINSON,
Kan. — 
Karen Hammersmith with the Reno County Health Department says she has spoken to the local doctors that work with kids and parents who are considering vaccinating their 12-15 year olds with the Pfizer vaccine once it is cleared later this week should talk to their doctor."They definitely want anybody that wants the vaccine to get the vaccine especially if you have some high-risk factors," Hammersmith said. "You can also get it if you don't have high-risk factors, because the vaccine is improved. We know that what it prevents is serious complications, which we have seen in that younger generation. We just haven't seen as much of that."It is the intent of the Health Department to get in some Pfizer vaccine, in light of the new developments."We plan to order the vaccine for next week," Hammersmith said. "Once a week, we put in an order to KDHE and then they get that from the federal government as to how much vaccine is available. We are going to order some Pfizer. It's got a little bit of an issue with the shelf life."The U.S. Food and Drug Administration in late February approved storage and transportation of the Pfizer vaccine at standard freezer temperatures for up to two weeks instead of ultra-cold conditions. Before that, it had required ultra-cold storage.Young adults are also encouraged to get their shots."We still want to push that vaccine out to those specifically in the 20 to 49-year-old group, too, that we have a lot less people vaccinated," Hammersmith said. "You can come as a family. We can get the parents, we can get the kids 12 and up all vaccinated at the same time."Until the county's shipment can get in, you can look at vaccinefinder.org to see who currently has the Pfizer shot.

Hammersmith: Talk to doc about vaccine for young teens

WASHINGTON (AP) —COVID-19 vaccines finally are headed for more kids as U.S. regulators on Monday expanded use of Pfizer’s shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class in the fall.

Shots could begin as soon as a federal vaccine advisory committee issues recommendations for using the two-dose vaccine in 12- to 15-year-olds, expected Wednesday.

Vaccinating children of all ages will be critical to a return to normalcy. Most COVID-19 vaccines rolling out worldwide have been authorized for adults. Pfizer’s vaccine is being used in multiple countries for teens as young as 16, and Canada recently became the first to expand use to 12 and up. Parents, school administrators and public health officials elsewhere are anxiously awaiting the shot to become available to more kids.

“This is a watershed moment in our ability to fight back the COVID-19 pandemic,” Dr. Bill Gruber, a Pfizer senior vice president who’s also a pediatrician, told The Associated Press.

The Food and Drug Administration declared the Pfizer vaccine is safe and offers strong protection for younger teens based on testing of more than 2,000 U.S. volunteers ages 12 to 15. The study found no cases of COVID-19 among fully vaccinated adolescents compared to 18 among kids given dummy shots. More intriguing, researchers found the kids developed higher levels of virus-fighting antibodies than earlier studies measured in young adults.

The younger teens received the same vaccine dosage as adults and had the same side effects, mostly sore arms and flu-like fever, chills or aches that signal a revved-up immune system, especially after the second dose.

Pfizer and its German partner BioNTech recently requested similar authorization in the European Union, with other countries to follow.

The latest news is welcome for U.S. families struggling to decide what activities are safe to resume when only the youngest family members remain unvaccinated.

“I can’t feel totally comfortable because my boys aren’t vaccinated,” said Carrie Vittitoe, a substitute teacher and freelance writer in Louisville, Kentucky, who is fully vaccinated as are her husband and 17-year-old daughter.

The FDA decision means her 13-year-old son soon could be eligible, leaving only her 11-year-old son who would be unvaccinated. The family hasn’t yet resumed going to church, and summer vacation will be a road trip so they don’t have to get on a plane.

“We can’t really go back to normal because two-fifths of our family don’t have protection,” Vittitoe said.

Pfizer isn’t the only company seeking to lower the age limit for its vaccine. Moderna recently said preliminary results from its study in 12- to 17-year-olds show strong protection and no serious side effects. Another U.S. company, Novavax, has a COVID-19 vaccine in late-stage development and just began a study in 12- to 17-year-olds as well.

Next up is testing whether the vaccine works for even younger children. Both Pfizer and Moderna have begun U.S. studies in children ages 6 months to 11 years. Those studies explore whether babies, preschoolers and elementary-age kids will need different doses than teens and adults. Gruber said Pfizer expects its first results sometime in the fall.

Outside of the U.S., AstraZeneca is studying its vaccine among 6- to 17-year-olds in Britain. And in China, Sinovac recently announced it has submitted preliminary data to Chinese regulators showing its vaccine is safe in children as young as 3.

Children are far less likely than adults to get seriously ill from COVID-19 yet they still have been hard-hit by the pandemic. They represent nearly 14% of the nation’s coronavirus cases. At least 296 have died from COVID-19 in the U.S. alone and more than 15,000 have been hospitalized, according to a tally by the American Academy of Pediatrics.

That’s not counting the toll of family members becoming ill or dying -- or the disruption to school, sports and other activities so crucial to children’s overall well-being.

“Children right now are struggling,” Gruber said. Plus, “we need as many people in the country who have the potential to transmit the virus to be protected.”

Experts say children must get the shots if the country is to vaccinate the 70% to 85% of the population necessary to reach what’s called herd immunity.

In the meantime, the Centers for Disease Control and Prevention says unvaccinated people -- including children -- should continue taking precautions such as wearing masks indoors and keeping their distance from other unvaccinated people outside of their households.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/12/1608677701818.png" alt="A worker at Truman Medical Center in Kansas City prepares doses of Pfizer-BioNTech's vaccine against the virus that causes COVID-19 -Photo courtesy Truman Medical Center" />
 <figcaption>A worker at Truman Medical Center in Kansas City prepares doses of Pfizer-BioNTech's vaccine against the virus that causes COVID-19 -Photo courtesy Truman Medical Center</figcaption>
 </figure>WASHINGTON (AP) —COVID-19 vaccines finally are headed for more kids as U.S. regulators on Monday expanded use of Pfizer’s shot to those as young as 12, sparking a race to protect middle and high school students before they head back to class in the fall.Shots could begin as soon as a federal vaccine advisory committee issues recommendations for using the two-dose vaccine in 12- to 15-year-olds, expected Wednesday.Vaccinating children of all ages will be critical to a return to normalcy. Most COVID-19 vaccines rolling out worldwide have been authorized for adults. Pfizer’s vaccine is being used in multiple countries for teens as young as 16, and Canada recently became the first to expand use to 12 and up. Parents, school administrators and public health officials elsewhere are anxiously awaiting the shot to become available to more kids.“This is a watershed moment in our ability to fight back the COVID-19 pandemic,” Dr. Bill Gruber, a Pfizer senior vice president who’s also a pediatrician, told The Associated Press.The Food and Drug Administration declared the Pfizer vaccine is safe and offers strong protection for younger teens based on testing of more than 2,000 U.S. volunteers ages 12 to 15. The study found no cases of COVID-19 among fully vaccinated adolescents compared to 18 among kids given dummy shots. More intriguing, researchers found the kids developed higher levels of virus-fighting antibodies than earlier studies measured in young adults.The younger teens received the same vaccine dosage as adults and had the same side effects, mostly sore arms and flu-like fever, chills or aches that signal a revved-up immune system, especially after the second dose.Pfizer and its German partner BioNTech recently requested similar authorization in the European Union, with other countries to follow.The latest news is welcome for U.S. families struggling to decide what activities are safe to resume when only the youngest family members remain unvaccinated.“I can’t feel totally comfortable because my boys aren’t vaccinated,” said Carrie Vittitoe, a substitute teacher and freelance writer in Louisville, Kentucky, who is fully vaccinated as are her husband and 17-year-old daughter.The FDA decision means her 13-year-old son soon could be eligible, leaving only her 11-year-old son who would be unvaccinated. The family hasn’t yet resumed going to church, and summer vacation will be a road trip so they don’t have to get on a plane.“We can’t really go back to normal because two-fifths of our family don’t have protection,” Vittitoe said.Pfizer isn’t the only company seeking to lower the age limit for its vaccine. Moderna recently said preliminary results from its study in 12- to 17-year-olds show strong protection and no serious side effects. Another U.S. company, Novavax, has a COVID-19 vaccine in late-stage development and just began a study in 12- to 17-year-olds as well.Next up is testing whether the vaccine works for even younger children. Both Pfizer and Moderna have begun U.S. studies in children ages 6 months to 11 years. Those studies explore whether babies, preschoolers and elementary-age kids will need different doses than teens and adults. Gruber said Pfizer expects its first results sometime in the fall.Outside of the U.S., AstraZeneca is studying its vaccine among 6- to 17-year-olds in Britain. And in China, Sinovac recently announced it has submitted preliminary data to Chinese regulators showing its vaccine is safe in children as young as 3.Children are far less likely than adults to get seriously ill from COVID-19 yet they still have been hard-hit by the pandemic. They represent nearly 14% of the nation’s coronavirus cases. At least 296 have died from COVID-19 in the U.S. alone and more than 15,000 have been hospitalized, according to a tally by the American Academy of Pediatrics.That’s not counting the toll of family members becoming ill or dying -- or the disruption to school, sports and other activities so crucial to children’s overall well-being.“Children right now are struggling,” Gruber said. Plus, “we need as many people in the country who have the potential to transmit the virus to be protected.”Experts say children must get the shots if the country is to vaccinate the 70% to 85% of the population necessary to reach what’s called herd immunity.In the meantime, the Centers for Disease Control and Prevention says unvaccinated people -- including children -- should continue taking precautions such as wearing masks indoors and keeping their distance from other unvaccinated people outside of their households.___

US children age 12-15 can now get Pfizer COVID shot 


HUTCHINSON,
Kan. — 
The death count attributed to COVID-19 in Reno County reached 140, so Hutch Post asked Reno County data analyst D.J. Gering to go back and let us know when each ten deaths were recorded by the county.

Those numbers are based on the reported date to the county rather than the official date of death.&nbsp; 

"For date of death numbers I cannot give the specific dates because it would risk identifying those persons if someone were to look up obituaries," Gering said in an email to Hutch Post. "We have to go off the date reported to the health department."

Because each month has multiple deaths, Gering was able to give us the deaths by month using the date of death measure:

There is not a specific graph for deaths on the dashboard due to the desire not to inadvertently identify individuals.

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/2/1612786086400.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>
HUTCHINSON,
Kan. — 
The death count attributed to COVID-19 in Reno County reached 140, so Hutch Post asked Reno County data analyst D.J. Gering to go back and let us know when each ten deaths were recorded by the county.10: October 17, 202020: November 8, 202030: November 14, 202040: November 20, 202050: December 1, 202060: December 7, 202070: December 11, 202080: December 15, 202090: December 23, 2020100: December 29, 2020110:&nbsp; January 12, 2021120: February 2, 2021130: February 8, 2021140: April 30, 2021Those numbers are based on the reported date to the county rather than the official date of death.&nbsp; "For date of death numbers I cannot give the specific dates because it would risk identifying those persons if someone were to look up obituaries," Gering said in an email to Hutch Post. "We have to go off the date reported to the health department."Because each month has multiple deaths, Gering was able to give us the deaths by month using the date of death measure:2020July: 1August: 1September: 4October: 15November: 39December: 512021January: 18February: 7March: 2April: 2There is not a specific graph for deaths on the dashboard due to the desire not to inadvertently identify individuals.

Look back at COVID-19 death count reveals slowdown in recent months


HUTCHINSON,
Kan. — 
KDHE's mobile lab is back Monday, May 3 behind Planet Fitness at 401 E 4th Ave. You can stop by for a FREE COVID test, Hepatitis A vaccine, or Johnson &amp; Johnson COVID vaccine. This is their last scheduled visit.

The lab was originally deployed to Hutchinson due to the recent upswing in Hepatitis A cases in Reno County. 

Hepatitis A is a vaccine-preventable liver infection caused by the hepatitis A Virus (HAV). The hepatitis A virus is found in fecal matter and blood of those infected. The virus is usually spread through close personal contact with an infected person or through eating contaminated food or drink. Common symptoms of the disease include jaundice (yellowing of the skin and eyes), dark urine, stomach pain, nausea and vomiting, and fever. The best way to prevent hepatitis A is to be vaccinated with the full, two-dose series.

The mobile lab is open from 8:00 a.m. to 4:30 p.m.

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/3/1614618511328.png" alt="" />
 <figcaption></figcaption>
 </figure>
HUTCHINSON,
Kan. — 
KDHE's mobile lab is back Monday, May 3 behind Planet Fitness at 401 E 4th Ave. You can stop by for a FREE COVID test, Hepatitis A vaccine, or Johnson &amp; Johnson COVID vaccine. This is their last scheduled visit.The lab was originally deployed to Hutchinson due to the recent upswing in Hepatitis A cases in Reno County. Hepatitis A is a vaccine-preventable liver infection caused by the hepatitis A Virus (HAV). The hepatitis A virus is found in fecal matter and blood of those infected. The virus is usually spread through close personal contact with an infected person or through eating contaminated food or drink. Common symptoms of the disease include jaundice (yellowing of the skin and eyes), dark urine, stomach pain, nausea and vomiting, and fever. The best way to prevent hepatitis A is to be vaccinated with the full, two-dose series.The mobile lab is open from 8:00 a.m. to 4:30 p.m.

Final scheduled day for KDHE mobile lab in Hutchinson Monday


HUTCHINSON,
Kan. — 
A risk-benefit analysis that guided nationwide recommendations regarding the Johnson and Johnson COVID-19 vaccine doses starting up again suggested that it is much safer for women of childbearing age to get that vaccine than to not be vaccinated at all.

"If you have been vaccinated, you're saving over 297 COVID-19 related hospitalizations, 56 ICU admissions and 6 deaths would be prevented," said Karen Hammersmith with the Reno County Health Department. "That's why it's extremely important to get vaccinated."

Many of those most at risk have been vaccinated, but even more people need to roll up their sleeves.

"We need to protect everybody by getting more adults vaccinated," Hammersmith said. "I can look at that in a positive light. We have over 41% of the adult population that are eligible to be, vaccinated."

Will the COVID-19 vaccine be a one-time thing, or a yearly shot like the flu shot? It's too early to tell.

"We don't know yet," Hammersmith said. "The vaccine's been out, now, close to six months. They've been doing studies on that, but the medical side of things started getting vaccinated in late, late December and early January. By June they're going to decide, do we need a booster dose, that we're considered that you wouldn't have to quarantine, but then you're going to move forward from that."

Anecdotally, Hammersmith said that for those who use a two-shot series like the Moderna, if they've had the virus, typically there is an immune response to the first shot. If they haven't been exposed, then the larger response is to the second dose.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1604716965620.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>
By
NICK GOSNELL
Hutch
Post
HUTCHINSON,
Kan. — 
A risk-benefit analysis that guided nationwide recommendations regarding the Johnson and Johnson COVID-19 vaccine doses starting up again suggested that it is much safer for women of childbearing age to get that vaccine than to not be vaccinated at all."If you have been vaccinated, you're saving over 297 COVID-19 related hospitalizations, 56 ICU admissions and 6 deaths would be prevented," said Karen Hammersmith with the Reno County Health Department. "That's why it's extremely important to get vaccinated."Many of those most at risk have been vaccinated, but even more people need to roll up their sleeves."We need to protect everybody by getting more adults vaccinated," Hammersmith said. "I can look at that in a positive light. We have over 41% of the adult population that are eligible to be, vaccinated."Will the COVID-19 vaccine be a one-time thing, or a yearly shot like the flu shot? It's too early to tell."We don't know yet," Hammersmith said. "The vaccine's been out, now, close to six months. They've been doing studies on that, but the medical side of things started getting vaccinated in late, late December and early January. By June they're going to decide, do we need a booster dose, that we're considered that you wouldn't have to quarantine, but then you're going to move forward from that."Anecdotally, Hammersmith said that for those who use a two-shot series like the Moderna, if they've had the virus, typically there is an immune response to the first shot. If they haven't been exposed, then the larger response is to the second dose.

Hammersmith: Vaccination still 'extremely important'


HUTCHINSON,
Kan. — 
Reno County schools remain in the yellow for next week. The case count and positive test rate numbers improved somewhat over last week.

According to the county's dashboard, the 14-day positive test rate is at 11.7% as of April 26, with 62 new cases in the past 14 days.

The case count numbers are slightly up from a week ago, with 39 active cases as of Thursday. 7,874 people have had the virus, with 7,696 recoveries.

The Reno County vaccination numbers have been updated for the week, as well. As of Wednesday, 21,803 Reno County residents have received at least one dose of COVID-19 vaccine. That's 34.92% of residents.

The county has had 139 deaths attributed to the virus. One of those has occurred in the last 30 days. Three people are in the hospital.

The health department is taking walk-ins for the Moderna vaccine for those 18 and older, or you can find the other types of vaccine at <a href="https://vaccinefinder.org/search/">vaccinefinder.org</a>.

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/2/1612955384439.png" alt="" />
 <figcaption></figcaption>
 </figure>
HUTCHINSON,
Kan. — 
Reno County schools remain in the yellow for next week. The case count and positive test rate numbers improved somewhat over last week.According to the county's dashboard, the 14-day positive test rate is at 11.7% as of April 26, with 62 new cases in the past 14 days.The case count numbers are slightly up from a week ago, with 39 active cases as of Thursday. 7,874 people have had the virus, with 7,696 recoveries.The Reno County vaccination numbers have been updated for the week, as well. As of Wednesday, 21,803 Reno County residents have received at least one dose of COVID-19 vaccine. That's 34.92% of residents.The county has had 139 deaths attributed to the virus. One of those has occurred in the last 30 days. Three people are in the hospital.The health department is taking walk-ins for the Moderna vaccine for those 18 and older, or you can find the other types of vaccine at <a href="https://vaccinefinder.org/search/">vaccinefinder.org</a>.

Positive test rate number down, schools remain in yellow


HUTCHINSON,
Kan. — Reno County schools are now in the yellow for next week. The case count and positive test rate numbers are continuing to climb over last week.

According to the county's dashboard, the 14-day positive test rate is up to 17.3% as of April 19, with 63 new cases in the past 14 days.

The case count numbers are down from a week ago, with 37 active cases as of Thursday. 7,831 people have had the virus, with 7,655 recoveries.

The Reno County vaccination numbers have been updated for the week, as well. As of Wednesday, 21,046 Reno County residents have received at least one dose of COVID-19 vaccine. That's 33.70% of residents.

The county has had 139 deaths attributed to the virus. Two of those have occurred in the last 30 days. One person is in the hospital.

The health department is taking walk-ins for the Moderna vaccine for those 18 and older, or you can find the other types of vaccine at vaccinefinder.org.

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/2/1612786086400.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>
HUTCHINSON,
Kan. — Reno County schools are now in the yellow for next week. The case count and positive test rate numbers are continuing to climb over last week.According to the county's dashboard, the 14-day positive test rate is up to 17.3% as of April 19, with 63 new cases in the past 14 days.The case count numbers are down from a week ago, with 37 active cases as of Thursday. 7,831 people have had the virus, with 7,655 recoveries.The Reno County vaccination numbers have been updated for the week, as well. As of Wednesday, 21,046 Reno County residents have received at least one dose of COVID-19 vaccine. That's 33.70% of residents.The county has had 139 deaths attributed to the virus. Two of those have occurred in the last 30 days. One person is in the hospital.The health department is taking walk-ins for the Moderna vaccine for those 18 and older, or you can find the other types of vaccine at vaccinefinder.org.

Schools in yellow for next week

NEW YORK (AP) — How long does protection from COVID-19 vaccines last?

Experts don’t know yet because they’re still studying vaccinated people to see when protection might wear off. How well the vaccines work against emerging variants will also determine if, when and how often additional shots might be needed.

“We only have information for as long as the vaccines have been studied,” said Deborah Fuller, a vaccine researcher at the University of Washington. “We have to study the vaccinated population and start to see, at what point do people become vulnerable again to the virus?”

So far, Pfizer’s ongoing trial indicates the company’s two-dose vaccine remains highly effective for at least six months, and likely longer. People who got Moderna’s vaccine also still had notable levels of virus-fighting antibodies six months after the second required shot.

Antibodies also don’t tell the whole story. To fight off intruders like viruses, our immune systems also have another line of defense called B and T cells, some of which can hang around long after antibody levels dwindle. If they encounter the same virus in the future, those battle-tested cells could potentially spring into action more quickly.

Even if they don’t prevent illness entirely, they could help blunt its severity. But exactly what role such “memory” cells might play with the coronavirus -- and for how long -- isn’t yet known.

While the current COVID-19 vaccines will likely last for at least about a year, they probably won’t offer lifelong protection, as with measles shots, said Dr. Kathleen Neuzil, a vaccine expert at the University of Maryland.

“It’s going to be somewhere in the middle of that very wide range,” she said.

Variants are another reason we might need an additional shot.

The current vaccines are designed to work against a particular spike protein on the coronavirus, said Mehul Suthar of the Emory Vaccine Center. If the virus mutates enough over time, vaccines might need to be updated to boost their effectiveness.

So far, the vaccines appear protective against the notable variants that have emerged, though somewhat less so on the one first detected in South Africa.

If it turns out we need another shot, a single dose could extend protection of the current shots or contain vaccination for one or more variants.

The need for follow-up shots will also depend partly on the success of the vaccination push globally, and tamping down transmission of the virus and emerging variants.

By CANDICE CHOI, Associated PressNEW YORK (AP) — How long does protection from COVID-19 vaccines last?Experts don’t know yet because they’re still studying vaccinated people to see when protection might wear off. How well the vaccines work against emerging variants will also determine if, when and how often additional shots might be needed.“We only have information for as long as the vaccines have been studied,” said Deborah Fuller, a vaccine researcher at the University of Washington. “We have to study the vaccinated population and start to see, at what point do people become vulnerable again to the virus?”So far, Pfizer’s ongoing trial indicates the company’s two-dose vaccine remains highly effective for at least six months, and likely longer. People who got Moderna’s vaccine also still had notable levels of virus-fighting antibodies six months after the second required shot.Antibodies also don’t tell the whole story. To fight off intruders like viruses, our immune systems also have another line of defense called B and T cells, some of which can hang around long after antibody levels dwindle. If they encounter the same virus in the future, those battle-tested cells could potentially spring into action more quickly.Even if they don’t prevent illness entirely, they could help blunt its severity. But exactly what role such “memory” cells might play with the coronavirus -- and for how long -- isn’t yet known.While the current COVID-19 vaccines will likely last for at least about a year, they probably won’t offer lifelong protection, as with measles shots, said Dr. Kathleen Neuzil, a vaccine expert at the University of Maryland.“It’s going to be somewhere in the middle of that very wide range,” she said.Variants are another reason we might need an additional shot.The current vaccines are designed to work against a particular spike protein on the coronavirus, said Mehul Suthar of the Emory Vaccine Center. If the virus mutates enough over time, vaccines might need to be updated to boost their effectiveness.So far, the vaccines appear protective against the notable variants that have emerged, though somewhat less so on the one first detected in South Africa.If it turns out we need another shot, a single dose could extend protection of the current shots or contain vaccination for one or more variants.The need for follow-up shots will also depend partly on the success of the vaccination push globally, and tamping down transmission of the virus and emerging variants.

Experts unsure how long protection from COVID vaccine lasts


HUTCHINSON,
Kan. — Durable medical equipment is something a lot of patients don't think about until they need it. However, Health E-Quip did have more demand during the pandemic.

"During COVID, obviously, we saw, definitely a really large uptick in the number of patients requiring oxygen therapy," said Bill Giersch, Chief Administrative Officer. "As a matter of fact, our patient load, we're serving about 500 patients. During COVID peak, we were serving probably closer to 650."

Respiratory Therapist Todd Hawk knows his job is to increase a patient's peace of mind.

"We had no idea how much it would change our role," Hawk said. "My role as a respiratory therapist for somebody getting equipment, it's to make them more comfortable with that equipment when they go home withit than when they came. It's scary when you get diagnosed and you say this is going to change every step of my sleep, every thing that I do."

Respiratory Therapist Kristen Yoder notes that it is the responsibility of Health E-Quip to make sure that your equipment is working as designed and according to the doctor's prescription.

"When it comes to oxygen, there is a specific oxygen requirement," Yoder said. "We can do portable testing, which is a whole other ballgame to address."

Health E-Quip is the only medical equipment company in Central Kansas with a certified repair center.

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/4/1618589009694.jpeg" alt="Health E-Quip Building Photo Courtesy Hutchinson Regional Healthcare System" />
 <figcaption>Health E-Quip Building Photo Courtesy Hutchinson Regional Healthcare System</figcaption>
 </figure>
By
NICK GOSNELL
Hutch
Post
HUTCHINSON,
Kan. — Durable medical equipment is something a lot of patients don't think about until they need it. However, Health E-Quip did have more demand during the pandemic."During COVID, obviously, we saw, definitely a really large uptick in the number of patients requiring oxygen therapy," said Bill Giersch, Chief Administrative Officer. "As a matter of fact, our patient load, we're serving about 500 patients. During COVID peak, we were serving probably closer to 650."Respiratory Therapist Todd Hawk knows his job is to increase a patient's peace of mind."We had no idea how much it would change our role," Hawk said. "My role as a respiratory therapist for somebody getting equipment, it's to make them more comfortable with that equipment when they go home withit than when they came. It's scary when you get diagnosed and you say this is going to change every step of my sleep, every thing that I do."Respiratory Therapist Kristen Yoder notes that it is the responsibility of Health E-Quip to make sure that your equipment is working as designed and according to the doctor's prescription."When it comes to oxygen, there is a specific oxygen requirement," Yoder said. "We can do portable testing, which is a whole other ballgame to address."Health E-Quip is the only medical equipment company in Central Kansas with a certified repair center.

Health E-Quip had increased demand during pandemic

WASHINGTON (AP) — The global death toll from the coronavirus topped a staggering 3 million people Saturday amid repeated setbacks in the worldwide vaccination campaign and a deepening crisis in places such as Brazil, India and France.

The number of lives lost, <a href="https://coronavirus.jhu.edu/map.html">as compiled by Johns Hopkins University</a>, is about equal to the population of Kyiv, Ukraine; Caracas, Venezuela; or metropolitan Lisbon, Portugal. It is bigger than Chicago (2.7 million) and equivalent to Philadelphia and Dallas combined.

And the true number is believed to be significantly higher because of possible government concealment and the many cases overlooked in the early stages of the outbreak that began in Wuhan, China, at the end of 2019.

When the world back in January passed the bleak threshold of 2 million deaths, immunization drives had just started in Europe and the United States. Today, they are underway in more than 190 countries, though progress in bringing the virus under control varies widely.

While the campaigns in the U.S. and Britain have hit their stride and people and businesses there are beginning to contemplate life after the pandemic, other places, mostly poorer countries but some rich ones as well, are lagging behind in putting shots in arms and have imposed new lockdowns and other restrictions as virus cases soar.

Worldwide, deaths are on the rise again, running at around 12,000 per day on average, and new cases are climbing too, eclipsing 700,000 a day.

“This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures,” said Maria Van Kerkhove, one of the World Health Organization’s leaders on COVID-19.

In Brazil, where deaths are running at about 3,000 per day, accounting for one-quarter of the lives lost worldwide in recent weeks, the crisis has been likened to a “raging inferno” by one WHO official. A more contagious variant of the virus has been rampaging across the country.

As cases surge, hospitals are running out of critical sedatives. As a result, there have been reports of some doctors diluting what supplies remain and even tying patients to their beds while breathing tubes are pushed down their throats.

The slow vaccine rollout has crushed Brazilians’ pride in their own history of carrying out huge immunization campaigns that were the envy of the developing world.

Taking cues from President Jair Bolsonaro, who has likened the virus to little more than a flu, his Health Ministry for months bet big on a single vaccine, ignoring other producers. When bottlenecks emerged, it was too late to get large quantities in time.

Watching so many patients suffer and die alone at her Rio de Janeiro hospital impelled nurse Lidiane Melo to take desperate measures.

In the early days of the pandemic, as sufferers were calling out for comfort that she was too busy to provide, Melo filled two rubber gloves with warm water, knotted them shut, and sandwiched them around a patient’s hand to simulate a loving touch.

Some have christened the practice the “hand of God,” and it is now the searing image of a nation roiled by a medical emergency with no end in sight.

“Patients can’t receive visitors. Sadly, there’s no way. So it’s a way to provide psychological support, to be there together with the patient holding their hand,” Melo said. She added: “And this year it’s worse, the seriousness of patients is 1,000 times greater.”

This situation is similarly dire in India, where cases spiked in February after weeks of steady decline, taking authorities by surprise. In a surge driven by variants of the virus, India saw over 180,000 new infections in one 24-hour span during the past week, bringing the total number of cases to over 13.9 million.

Problems that India had overcome last year are coming back to haunt health officials. Only 178 ventilators were free Wednesday afternoon in New Delhi, a city of 29 million, where 13,000 new infections were reported the previous day.

The challenges facing India reverberate beyond its borders since the country is the biggest supplier of shots to COVAX, the U.N.-sponsored program to distribute vaccines to poorer parts of the world. Last month, India said it would suspend vaccine exports until the virus’s spread inside the country slows.

The WHO recently described the supply situation as precarious. Up to 60 countries might not receive any more shots until June, by one estimate. To date, COVAX has delivered about 40 million doses to more than 100 countries, enough to cover barely 0.25% of the world’s population.

Globally, about 87% of the 700 million doses dispensed have been given out in rich countries. While 1 in 4 people in wealthy nations have received a vaccine, in poor countries the figure is 1 in more than 500.

In recent days, the U.S. and some European countries put the use of Johnson &amp; Johnson’s COVID-19 vaccine on hold while authorities investigate extremely rare but dangerous blood clots. AstraZeneca’s vaccine has likewise been hit with delays and restrictions because of a clotting scare.

Another concern: Poorer countries are relying on vaccines made by China and Russia, which some scientists believe provide less protection than those made by Pfizer, Moderna and AstraZeneca.

Last week, the director of the Chinese Center for Disease Control and Prevention acknowledged the country’s vaccines offer low protection and said officials are considering mixing them with other shots to improve their effectiveness.

In the U.S., where over 560,000 lives have been lost, accounting for more than 1 in 6 of the world’s COVID-19 deaths, hospitalizations and deaths have dropped, businesses are reopening, and life is beginning to return to something approaching normalcy in several states. The number of Americans filing for unemployment benefits tumbled last week to 576,000, a post-COVID-19 low.

But progress has been patchy, and new hot spots — most notably Michigan — have flared up in recent weeks. Still, deaths in the U.S. are down to about 700 per day on average, plummeting from a mid-January peak of about 3,400.

In Europe, countries are feeling the brunt of a more contagious variant that first ravaged Britain and has pushed the continent’s COVID-19-related death toll beyond 1 million.

Close to 6,000 gravely ill patients are being treated in French critical care units, numbers not seen since the first wave a year ago.

Dr. Marc Leone, head of intensive care at the North Hospital in Marseille, said exhausted front-line staff members who were feted as heroes at the start of the pandemic now feel alone and are clinging to hope that renewed school closings and other restrictions will help curb the virus in the coming weeks.

“There’s exhaustion, more bad tempers. You have to tread carefully because there are a lot of conflicts,” he said. “We’ll give everything we have to get through these 15 days as best we can.”

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/4/1618692413792.png" alt="John Hopkins -Number of Daily Deaths" />
 <figcaption>John Hopkins -Number of Daily Deaths</figcaption>
 </figure>WASHINGTON (AP) — The global death toll from the coronavirus topped a staggering 3 million people Saturday amid repeated setbacks in the worldwide vaccination campaign and a deepening crisis in places such as Brazil, India and France.The number of lives lost, <a href="https://coronavirus.jhu.edu/map.html">as compiled by Johns Hopkins University</a>, is about equal to the population of Kyiv, Ukraine; Caracas, Venezuela; or metropolitan Lisbon, Portugal. It is bigger than Chicago (2.7 million) and equivalent to Philadelphia and Dallas combined.And the true number is believed to be significantly higher because of possible government concealment and the many cases overlooked in the early stages of the outbreak that began in Wuhan, China, at the end of 2019.When the world back in January passed the bleak threshold of 2 million deaths, immunization drives had just started in Europe and the United States. Today, they are underway in more than 190 countries, though progress in bringing the virus under control varies widely.While the campaigns in the U.S. and Britain have hit their stride and people and businesses there are beginning to contemplate life after the pandemic, other places, mostly poorer countries but some rich ones as well, are lagging behind in putting shots in arms and have imposed new lockdowns and other restrictions as virus cases soar.Worldwide, deaths are on the rise again, running at around 12,000 per day on average, and new cases are climbing too, eclipsing 700,000 a day.“This is not the situation we want to be in 16 months into a pandemic, where we have proven control measures,” said Maria Van Kerkhove, one of the World Health Organization’s leaders on COVID-19.In Brazil, where deaths are running at about 3,000 per day, accounting for one-quarter of the lives lost worldwide in recent weeks, the crisis has been likened to a “raging inferno” by one WHO official. A more contagious variant of the virus has been rampaging across the country.As cases surge, hospitals are running out of critical sedatives. As a result, there have been reports of some doctors diluting what supplies remain and even tying patients to their beds while breathing tubes are pushed down their throats.The slow vaccine rollout has crushed Brazilians’ pride in their own history of carrying out huge immunization campaigns that were the envy of the developing world.Taking cues from President Jair Bolsonaro, who has likened the virus to little more than a flu, his Health Ministry for months bet big on a single vaccine, ignoring other producers. When bottlenecks emerged, it was too late to get large quantities in time.Watching so many patients suffer and die alone at her Rio de Janeiro hospital impelled nurse Lidiane Melo to take desperate measures.In the early days of the pandemic, as sufferers were calling out for comfort that she was too busy to provide, Melo filled two rubber gloves with warm water, knotted them shut, and sandwiched them around a patient’s hand to simulate a loving touch.Some have christened the practice the “hand of God,” and it is now the searing image of a nation roiled by a medical emergency with no end in sight.“Patients can’t receive visitors. Sadly, there’s no way. So it’s a way to provide psychological support, to be there together with the patient holding their hand,” Melo said. She added: “And this year it’s worse, the seriousness of patients is 1,000 times greater.”This situation is similarly dire in India, where cases spiked in February after weeks of steady decline, taking authorities by surprise. In a surge driven by variants of the virus, India saw over 180,000 new infections in one 24-hour span during the past week, bringing the total number of cases to over 13.9 million.Problems that India had overcome last year are coming back to haunt health officials. Only 178 ventilators were free Wednesday afternoon in New Delhi, a city of 29 million, where 13,000 new infections were reported the previous day.The challenges facing India reverberate beyond its borders since the country is the biggest supplier of shots to COVAX, the U.N.-sponsored program to distribute vaccines to poorer parts of the world. Last month, India said it would suspend vaccine exports until the virus’s spread inside the country slows.The WHO recently described the supply situation as precarious. Up to 60 countries might not receive any more shots until June, by one estimate. To date, COVAX has delivered about 40 million doses to more than 100 countries, enough to cover barely 0.25% of the world’s population.Globally, about 87% of the 700 million doses dispensed have been given out in rich countries. While 1 in 4 people in wealthy nations have received a vaccine, in poor countries the figure is 1 in more than 500.In recent days, the U.S. and some European countries put the use of Johnson &amp; Johnson’s COVID-19 vaccine on hold while authorities investigate extremely rare but dangerous blood clots. AstraZeneca’s vaccine has likewise been hit with delays and restrictions because of a clotting scare.Another concern: Poorer countries are relying on vaccines made by China and Russia, which some scientists believe provide less protection than those made by Pfizer, Moderna and AstraZeneca.Last week, the director of the Chinese Center for Disease Control and Prevention acknowledged the country’s vaccines offer low protection and said officials are considering mixing them with other shots to improve their effectiveness.In the U.S., where over 560,000 lives have been lost, accounting for more than 1 in 6 of the world’s COVID-19 deaths, hospitalizations and deaths have dropped, businesses are reopening, and life is beginning to return to something approaching normalcy in several states. The number of Americans filing for unemployment benefits tumbled last week to 576,000, a post-COVID-19 low.But progress has been patchy, and new hot spots — most notably Michigan — have flared up in recent weeks. Still, deaths in the U.S. are down to about 700 per day on average, plummeting from a mid-January peak of about 3,400.In Europe, countries are feeling the brunt of a more contagious variant that first ravaged Britain and has pushed the continent’s COVID-19-related death toll beyond 1 million.Close to 6,000 gravely ill patients are being treated in French critical care units, numbers not seen since the first wave a year ago.Dr. Marc Leone, head of intensive care at the North Hospital in Marseille, said exhausted front-line staff members who were feted as heroes at the start of the pandemic now feel alone and are clinging to hope that renewed school closings and other restrictions will help curb the virus in the coming weeks.“There’s exhaustion, more bad tempers. You have to tread carefully because there are a lot of conflicts,” he said. “We’ll give everything we have to get through these 15 days as best we can.”

Global COVID deaths on the rise again, top 3 million


HUTCHINSON,
Kan. — 
Reno County schools remain in the green for next week, even though the case count and positive test rate numbers are beginning to increase again.

According to the county's dashboard, the 14-day positive test rate is up to 11.1% as of April 12, with 45 new cases in the past 14 days.

The case count numbers are up as well, with 41 active cases as of Thursday.&nbsp;7,805 people have had the virus, with&nbsp;7,627 recoveries.

The Reno County vaccination numbers have been updated for the week, as well. As of Wednesday, 20,375 Reno County residents have received at least one dose of COVID-19 vaccine. That's 32.63% of residents.

The county has had 137 deaths attributed to the virus, but just one of those has occurred in the last 30 days. Just two people are in the hospital.

The last of the major second-shot clinics at the Sports Arena for those who received their first vaccination in mid-March is Friday.

<figure>
 <img src="https://media.eaglewebservices.com/public/2021/2/1612955384439.png" alt="" />
 <figcaption></figcaption>
 </figure>
HUTCHINSON,
Kan. — 
Reno County schools remain in the green for next week, even though the case count and positive test rate numbers are beginning to increase again.According to the county's dashboard, the 14-day positive test rate is up to 11.1% as of April 12, with 45 new cases in the past 14 days.The case count numbers are up as well, with 41 active cases as of Thursday.&nbsp;7,805 people have had the virus, with&nbsp;7,627 recoveries.The Reno County vaccination numbers have been updated for the week, as well. As of Wednesday, 20,375 Reno County residents have received at least one dose of COVID-19 vaccine. That's 32.63% of residents.The county has had 137 deaths attributed to the virus, but just one of those has occurred in the last 30 days. Just two people are in the hospital.The last of the major second-shot clinics at the Sports Arena for those who received their first vaccination in mid-March is Friday.

County schools remain in green, though PTR is back above 10%

TOPEKA – A Centers for Disease Control and Prevention (CDC) Emerging Variant known as the Brazilian or P.1 variant has been identified in an individual in Sedgwick County. 

A case investigation is being conducted to determine how the person became infected with this particular variant of the SARS-CoV-2 virus, as well as, if others may have been exposed. No further details will be released concerning the patient, including demographics.

The variant was determined through the whole genome sequencing conducted through the laboratories at the Kansas Department of Health and Environment (KDHE).

The P.1 variant was originally identified in four travelers from Brazil, who were tested during routine screening at Haneda airport outside Tokyo, Japan. 

This variant was detected in the U.S. at the end of January 2021 and has been&nbsp;<a href="https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDAsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA0MTMuMzg3MDgwNDEiLCJ1cmwiOiJodHRwczovL3d3dy5jZGMuZ292L2Nvcm9uYXZpcnVzLzIwMTktbmNvdi90cmFuc21pc3Npb24vdmFyaWFudC1jYXNlcy5odG1sP3V0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSJ9.-0O-9-5IJTolc4wspUsudU4lji1mIZypKY8N4R-85iQ/s/1305913448/br/101976527309-l" target="_blank">found in 31 states and territories</a>&nbsp;in the U.S. At this point, there is still much to learn about the transmission characteristics and potential severity of the P.1 variant. Although this strain can reduce the effectiveness of some vaccines, vaccines still provide strong protection against severe illness and death.

“We continue to encourage people to take the appropriate precautions. This includes wearing a mask that fits snuggly around the nose and face and has multiple layers of fabric or layering thinner masks with an additional cloth face mask to improve the fit,” Dr. Lee Norman, KDHE Secretary, said. “Kansans should also follow isolation and quarantine recommendations, practice physical distancing, good hygiene, staying home if ill and getting the vaccine if you are able to.”

Two other variants of concern have been identified in Kansas, including the UK variant, B.1.1.7, and the South African variant, B.1.351. Variant information in Kansas can be found on the&nbsp;<a href="https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA0MTMuMzg3MDgwNDEiLCJ1cmwiOiJodHRwczovL3d3dy5jb3JvbmF2aXJ1cy5rZGhla3MuZ292LzE2MC9DT1ZJRC0xOS1pbi1LYW5zYXM_dXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5In0.a6rqq0vuenhfl1r_L-wUWD8_7IdAZBLRbMDQNKguKPM/s/1305913448/br/101976527309-l" target="_blank">COVID-19 dashboard</a>&nbsp;under the “Variants” tab.

“In addition to following these healthy behaviors, this finding also shows the importance of getting tested for COVID-19,” Adrienne Byrne, Sedgwick County Health Director, adds.

Testing is available and free for all Kansans. To find a location near you, visit:&nbsp;<a href="https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDIsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA0MTMuMzg3MDgwNDEiLCJ1cmwiOiJodHRwOi8vd3d3LmNvcm9uYXZpcnVzLmtkaGVrcy5nb3YvMjgwL0NPVklELTE5LVRlc3Rpbmc_dXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5In0.s-jifUbFDBcqbLVz4HKQIs6RcJ95wptgslZfZQG_61o/s/1305913448/br/101976527309-l" target="_blank">www.coronavirus.kdheks.gov/280/COVID-19-Testing</a>.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/12/1608566572342.png" alt="VIrus variant image courtesy GISAID" />
 <figcaption>VIrus variant image courtesy GISAID</figcaption>
 </figure>TOPEKA – A Centers for Disease Control and Prevention (CDC) Emerging Variant known as the Brazilian or P.1 variant has been identified in an individual in Sedgwick County. A case investigation is being conducted to determine how the person became infected with this particular variant of the SARS-CoV-2 virus, as well as, if others may have been exposed. No further details will be released concerning the patient, including demographics.The variant was determined through the whole genome sequencing conducted through the laboratories at the Kansas Department of Health and Environment (KDHE).The P.1 variant was originally identified in four travelers from Brazil, who were tested during routine screening at Haneda airport outside Tokyo, Japan. This variant was detected in the U.S. at the end of January 2021 and has been&nbsp;<a href="https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDAsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA0MTMuMzg3MDgwNDEiLCJ1cmwiOiJodHRwczovL3d3dy5jZGMuZ292L2Nvcm9uYXZpcnVzLzIwMTktbmNvdi90cmFuc21pc3Npb24vdmFyaWFudC1jYXNlcy5odG1sP3V0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSJ9.-0O-9-5IJTolc4wspUsudU4lji1mIZypKY8N4R-85iQ/s/1305913448/br/101976527309-l" target="_blank">found in 31 states and territories</a>&nbsp;in the U.S. At this point, there is still much to learn about the transmission characteristics and potential severity of the P.1 variant. Although this strain can reduce the effectiveness of some vaccines, vaccines still provide strong protection against severe illness and death.“We continue to encourage people to take the appropriate precautions. This includes wearing a mask that fits snuggly around the nose and face and has multiple layers of fabric or layering thinner masks with an additional cloth face mask to improve the fit,” Dr. Lee Norman, KDHE Secretary, said. “Kansans should also follow isolation and quarantine recommendations, practice physical distancing, good hygiene, staying home if ill and getting the vaccine if you are able to.”<figure>
 <img src="https://media.eaglewebservices.com/public/2021/4/1618343095662.png" alt="Tuesday April 13, 2021 KDHE image" />
 <figcaption>Tuesday April 13, 2021 KDHE image</figcaption>
 </figure>Two other variants of concern have been identified in Kansas, including the UK variant, B.1.1.7, and the South African variant, B.1.351. Variant information in Kansas can be found on the&nbsp;<a href="https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA0MTMuMzg3MDgwNDEiLCJ1cmwiOiJodHRwczovL3d3dy5jb3JvbmF2aXJ1cy5rZGhla3MuZ292LzE2MC9DT1ZJRC0xOS1pbi1LYW5zYXM_dXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5In0.a6rqq0vuenhfl1r_L-wUWD8_7IdAZBLRbMDQNKguKPM/s/1305913448/br/101976527309-l" target="_blank">COVID-19 dashboard</a>&nbsp;under the “Variants” tab.“In addition to following these healthy behaviors, this finding also shows the importance of getting tested for COVID-19,” Adrienne Byrne, Sedgwick County Health Director, adds.Testing is available and free for all Kansans. To find a location near you, visit:&nbsp;<a href="https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDIsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA0MTMuMzg3MDgwNDEiLCJ1cmwiOiJodHRwOi8vd3d3LmNvcm9uYXZpcnVzLmtkaGVrcy5nb3YvMjgwL0NPVklELTE5LVRlc3Rpbmc_dXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5In0.s-jifUbFDBcqbLVz4HKQIs6RcJ95wptgslZfZQG_61o/s/1305913448/br/101976527309-l" target="_blank">www.coronavirus.kdheks.gov/280/COVID-19-Testing</a>.

Brazilian COVID variant identified in Kansas

WASHINGTON (AP) — The U.S. is recommending a “pause” in administration of the single-dose Johnson &amp; Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&amp;J vaccine have been administered in the U.S.

U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&amp;J shot, and states and other providers are expected to follow.

CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases.

“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.

WASHINGTON (AP) — The U.S. is recommending a “pause” in administration of the single-dose Johnson &amp; Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&amp;J vaccine have been administered in the U.S.U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&amp;J shot, and states and other providers are expected to follow.CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation of the cases.“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.

US recommends 'pause' of Johnson & Johnson vaccine 


HUTCHINSON,
Kan. — Beth Akins with Horizons Mental Health Center notes that there have been both good and bad consequences of the COVID-19 pandemic.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/4/1587129819284.jpeg" alt="" />
 <figcaption></figcaption>
 </figure>
By
NICK GOSNELL
Hutch
Post
HUTCHINSON,
Kan. — Beth Akins with Horizons Mental Health Center notes that there have been both good and bad consequences of the COVID-19 pandemic."Do I think the pandemic has caused some issues with mental health?" Akins asked rhetorically. "My answer to that is going to be yes. We have seen an increase in calls to our crisis lines. We all have sort of coping strategies that we have adopted that help us deal with just that kind of day to day stress or day to day anxiety. One of the things that the pandemic did was take away those normal coping strategies."Those might include going out to dinner with friends or going to the gym or other activities that were made either more difficult or impossible by the pandemic. On the other hand, figuring out how to give care through the phone and internet has resulted in some people being able to keep therapy appointments that would have otherwise had to be cancelled."We'd often times have people call and cancel because they didn't have transportation or their childcare fell through," Akins said. "Now, when they call, instead of cancelling, we can say to them, hey let's just switch this appointment to televideo."In the beginning of the pandemic, there was so much uncertainty and so much change in routine that it actually helped some people who may have had additional stress from workplace issues that were working from home, for example, but now that the new routines are set up, people are beginning to feel overwhelmed by the new stressors, not to mention the prospect of going back to a normal that they were struggling with before."Lots of people have experienced a tremendous amount of loss," Akins said. "The grief is more intense now, just because I know multiple people who died in this last year, that type of a thing."The Horizons 24-hour crisis line received nearly 500 calls in 2020, up from the mid 300s in 2019.
<a href="https://hutchpost.com/download" target="_blank">CLICK
HERE</a>&nbsp;to
download the Hutch Post mobile app. 
<a href="https://hutchpost.com/posts/5e73b532afae0f4d5f5d90ea" target="_blank">CLICK
HERE</a>&nbsp;to
sign up for the daily Hutch Post email news update.

Coronavirus Update